C‑MER Medical Holdings (SEHK:3309) Profit Turnaround Tests Bullish Narratives On Sustainability

Simply Wall St.03-29

C-MER Medical Holdings (SEHK:3309) opened FY 2025 with first half revenue of HK$944.3 million and basic EPS of HK$0.041, setting a cleaner profit picture after previous swings between profit and loss....

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2623335536?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","is_english":true,"pubTime":"2026-03-29 05:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2623335536","market":"us","top_or_hot":-1,"title":"C‑MER Medical Holdings (SEHK:3309) Profit Turnaround Tests Bullish Narratives On Sustainability","media":"Simply Wall St.","content":"<div>\n<p>C-MER Medical Holdings (SEHK:3309) opened FY 2025 with first half revenue of HK$944.3 million and basic EPS of HK$0.041, setting a cleaner profit picture after previous swings between profit and loss....</p>\n\n<a href=\"https://simplywall.st/stocks/hk/healthcare/hkg-3309/c-mer-medical-holdings-shares/news/cmer-medical-holdings-sehk3309-profit-turnaround-tests-bulli\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>C‑MER Medical Holdings (SEHK:3309) Profit Turnaround Tests Bullish Narratives On Sustainability</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nC‑MER Medical Holdings (SEHK:3309) Profit Turnaround Tests Bullish Narratives On Sustainability\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-29 05:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/hk/healthcare/hkg-3309/c-mer-medical-holdings-shares/news/cmer-medical-holdings-sehk3309-profit-turnaround-tests-bulli><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>C-MER Medical Holdings (SEHK:3309) opened FY 2025 with first half revenue of HK$944.3 million and basic EPS of HK$0.041, setting a cleaner profit picture after previous swings between profit and loss....</p>\n\n<a href=\"https://simplywall.st/stocks/hk/healthcare/hkg-3309/c-mer-medical-holdings-shares/news/cmer-medical-holdings-sehk3309-profit-turnaround-tests-bulli\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BLSX","symbol_name":"Tradr 2X Long BLSH Daily ETF","start_time":0,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-3309/c-mer-medical-holdings-shares/news/cmer-medical-holdings-sehk3309-profit-turnaround-tests-bulli","article_id":"2623335536","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-3309/c-mer-medical-holdings-shares/news/cmer-medical-holdings-sehk3309-profit-turnaround-tests-bulli","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2623335536","pubTimestamp":1774732277,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"C-MER Medical Holdings (SEHK:3309) opened FY 2025 with first half revenue of HK$944.3 million and basic EPS of HK$0.041, setting a cleaner profit picture after previous swings between profit and loss. Over the last three reported half years, revenue has moved from HK$922.5 million in 1H 2024 to HK$990.7 million in 2H 2024 and HK$944.3 million in 1H 2025. Over the same periods, basic EPS shifted from HK$0.024 to a loss of HK$0.135 and back to a profit of HK$0.041, giving investors a clearer...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BLSX":"Tradr 2X Long BLSH Daily ETF","BK1209":"保健护理机构","BK4112":"金融交易所和数据","03309":"希玛医疗","BLSG":"2倍做多BLSH ETF-Leverage Shares","BK1219":"保健护理服务","BK1516":"腾讯概念"},"translate_title":"C-MER Medical Holdings(SEHK：3309)利润扭亏为盈考验可持续发展的看涨叙事","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BLSG":0.6,"BLSX":0.6,"03309":1.98},"content_text":"C-MER Medical Holdings (SEHK:3309) opened FY 2025 with first half revenue of HK$944.3 million and basic EPS of HK$0.041, setting a cleaner profit picture after previous swings between profit and loss. Over the last three reported half years, revenue has moved from HK$922.5 million in 1H 2024 to HK$990.7 million in 2H 2024 and HK$944.3 million in 1H 2025. Over the same periods, basic EPS shifted from HK$0.024 to a loss of HK$0.135 and back to a profit of HK$0.041, giving investors a clearer read on how margins are settling. See our full analysis for C-MER Medical Holdings. With the headline numbers on the table, the next step is to see how this profit recovery and margin profile line up with the most widely held narratives around C-MER Medical Holdings. Curious how numbers become stories that shape markets? Explore Community Narratives SEHK:3309 Revenue & Expenses Breakdown as at Mar 2026 AdvertisementTwelve month profit of HK$100.4 million breaks from five year EPS trend  On a trailing twelve month view, C-MER generated HK$1,946.7 million in revenue and HK$100.4 million in net income, compared with a five year annualised earnings trend of 23.7% decline per year. What stands out for the bullish view is that this HK$100.4 million profit and 0.0833 HK$ trailing EPS directly contrast with that five year average earnings decline, which:\n     Strongly supports the bullish argument that the company has moved into a different profit phase over the last year, using the shift from a 165.9 million loss in 2H 2024 to a 49.9 million profit in 1H 2025 as evidence of that change. At the same time challenges bullish investors to consider that one profitable twelve month stretch sits against a longer history of weaker earnings, so they may want to see how consistently figures like the HK$49.9 million half year profit can be repeated.    15x P/E at HK$1.27 versus DCF fair value of HK$3.04  At the current share price of HK$1.27, the stock is described as trading around 58.3% below a DCF fair value of HK$3.04 while sitting on a trailing P/E of 15x. Bears focus on that 15x P/E being above the 11.3x Hong Kong healthcare average and higher than the peer measure of around 4.7x in absolute terms, and this creates a clear tension with the reported DCF discount, because:\n     Critics highlight that paying 15x trailing earnings for a company whose five year earnings trend averaged 23.7% decline per year may look rich versus peers even if the share price is below a DCF estimate. What is equally important is that the same trailing data calling earnings \"high quality\" over the past year can be used by more cautious investors to justify that premium P/E only if profit figures such as the HK$100.4 million trailing net income remain stable.    Revenue near HK$1.0 billion per half gives scale to the new profit profile  Across the last three reported half years, revenue sat at HK$922.5 million, HK$990.7 million and HK$944.3 million, which frames the HK$49.9 million 1H 2025 net income as profit earned on close to HK$1.0 billion of sales in a typical half. The prevailing narrative around C-MER as a broader medical services group rather than only an eye care chain finds some support in these figures, because:\n     Supporters point out that maintaining revenue close to HK$1.0 billion per half while moving from a 165.9 million loss in 2H 2024 to a 100.4 million profit over the latest twelve months fits a bullish story of the wider platform starting to contribute to a cleaner profit base. On the other hand, cautious investors may look at that scale of revenue against the history of five year earnings decline and treat the recent HK$49.9 million half year profit as a starting point rather than proof that every segment is already pulling its weight.    📊 Read the what the Community is saying about C-MER Medical Holdings. Next Steps Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on C-MER Medical Holdings's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move. If this combination of profit recovery and past earnings weakness leaves you uncertain, review the underlying data now and compare it with 2 key rewards See What Else Is Out There C-MER's profit recovery sits against a five year record of 23.7% annualised earnings decline and a P/E above sector averages, which may concern valuation focused investors. If that mix of past earnings weakness and premium pricing feels uncomfortable, use the 239 high quality undervalued stocks to quickly spot companies where current valuations better reflect recent profit performance.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2623335536","isCrawlerRequest":true}